These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

336 related items for PubMed ID: 17324959

  • 1. Potent, synergistic inhibition of Staphylococcus aureus upon exposure to a combination of the endopeptidase lysostaphin and the cationic peptide ranalexin.
    Graham S, Coote PJ.
    J Antimicrob Chemother; 2007 Apr; 59(4):759-62. PubMed ID: 17324959
    [Abstract] [Full Text] [Related]

  • 2. In vivo efficacy of the antimicrobial peptide ranalexin in combination with the endopeptidase lysostaphin against wound and systemic meticillin-resistant Staphylococcus aureus (MRSA) infections.
    Desbois AP, Gemmell CG, Coote PJ.
    Int J Antimicrob Agents; 2010 Jun; 35(6):559-65. PubMed ID: 20206480
    [Abstract] [Full Text] [Related]

  • 3. Surface disinfection properties of the combination of an antimicrobial peptide, ranalexin, with an endopeptidase, lysostaphin, against methicillin-resistant Staphylococcus aureus (MRSA).
    Desbois AP, Lang S, Gemmell CG, Coote PJ.
    J Appl Microbiol; 2010 Feb; 108(2):723-30. PubMed ID: 19709343
    [Abstract] [Full Text] [Related]

  • 4. MRSA decolonization of cotton rat nares by a combination treatment comprising lysostaphin and the antimicrobial peptide ranalexin.
    Desbois AP, Sattar A, Graham S, Warn PA, Coote PJ.
    J Antimicrob Chemother; 2013 Nov; 68(11):2569-75. PubMed ID: 23800902
    [Abstract] [Full Text] [Related]

  • 5. In vitro activity of lysostaphin, mupirocin, and tea tree oil against clinical methicillin-resistant Staphylococcus aureus.
    LaPlante KL.
    Diagn Microbiol Infect Dis; 2007 Apr; 57(4):413-8. PubMed ID: 17141452
    [Abstract] [Full Text] [Related]

  • 6. Comparison of four methods for determining lysostaphin susceptibility of various strains of Staphylococcus aureus.
    Kusuma CM, Kokai-Kun JF.
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3256-63. PubMed ID: 16048934
    [Abstract] [Full Text] [Related]

  • 7. Secretory ranalexin produced in recombinant Pichia pastoris exhibits additive or synergistic bactericidal activity when used in combination with polymyxin B or linezolid against multi-drug resistant bacteria.
    Aleinein RA, Schäfer H, Wink M.
    Biotechnol J; 2014 Jan; 9(1):110-9. PubMed ID: 24166764
    [Abstract] [Full Text] [Related]

  • 8. Polyamine effects on antibiotic susceptibility in bacteria.
    Kwon DH, Lu CD.
    Antimicrob Agents Chemother; 2007 Jun; 51(6):2070-7. PubMed ID: 17438056
    [Abstract] [Full Text] [Related]

  • 9. The phage K lytic enzyme LysK and lysostaphin act synergistically to kill MRSA.
    Becker SC, Foster-Frey J, Donovan DM.
    FEMS Microbiol Lett; 2008 Oct; 287(2):185-91. PubMed ID: 18721148
    [Abstract] [Full Text] [Related]

  • 10. Lysostaphin: an antistaphylococcal agent.
    Kumar JK.
    Appl Microbiol Biotechnol; 2008 Sep; 80(4):555-61. PubMed ID: 18607587
    [Abstract] [Full Text] [Related]

  • 11. Lysostaphin as a treatment for systemic Staphylococcus aureus infection in a mouse model.
    Kokai-Kun JF, Chanturiya T, Mond JJ.
    J Antimicrob Chemother; 2007 Nov; 60(5):1051-9. PubMed ID: 17848374
    [Abstract] [Full Text] [Related]

  • 12. Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus.
    Warfield R, Bardelang P, Saunders H, Chan WC, Penfold C, James R, Thomas NR.
    Org Biomol Chem; 2006 Oct 07; 4(19):3626-38. PubMed ID: 16990938
    [Abstract] [Full Text] [Related]

  • 13. Cationic peptide of the male reproductive tract, HE2alpha, displays antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis.
    Liao M, Ruddock PS, Rizvi AS, Hall SH, French FS, Dillon JR.
    J Antimicrob Chemother; 2005 Nov 07; 56(5):957-61. PubMed ID: 16195256
    [Abstract] [Full Text] [Related]

  • 14. In vitro antimicrobial efficacy of riboflavin and ultraviolet light on Staphylococcus aureus, methicillin-resistant Staphylococcus aureus, and Pseudomonas aeruginosa.
    Schrier A, Greebel G, Attia H, Trokel S, Smith EF.
    J Refract Surg; 2009 Sep 07; 25(9):S799-802. PubMed ID: 19772254
    [Abstract] [Full Text] [Related]

  • 15. In vitro activity of MSI-78 alone and in combination with antibiotics against bacteria responsible for bloodstream infections in neutropenic patients.
    Giacometti A, Cirioni O, Kamysz W, D'Amato G, Silvestri C, Licci A, Nadolski P, Riva A, Lukasiak J, Scalise G.
    Int J Antimicrob Agents; 2005 Sep 07; 26(3):235-40. PubMed ID: 16122911
    [Abstract] [Full Text] [Related]

  • 16. Assessment of the in vitro efficacy of the novel antimicrobial peptide CECT7121 against human Gram-positive bacteria from serious infections refractory to treatment.
    Sparo MD, Jones DG, Sánchez Bruni SF.
    Chemotherapy; 2009 Sep 07; 55(4):270-7. PubMed ID: 19494489
    [Abstract] [Full Text] [Related]

  • 17. Antimicrobial susceptibility of Gram-positive bacterial isolates from the Asia-Pacific region and an in vitro evaluation of the bactericidal activity of daptomycin, vancomycin, and teicoplanin: a SENTRY Program Report (2003-2004).
    Biedenbach DJ, Bell JM, Sader HS, Fritsche TR, Jones RN, Turnidge JD.
    Int J Antimicrob Agents; 2007 Aug 07; 30(2):143-9. PubMed ID: 17531446
    [Abstract] [Full Text] [Related]

  • 18. In vitro activity of recombinant lysostaphin-antibiotic combinations toward methicillin-resistant Staphylococcus aureus.
    Polak J, Della Latta P, Blackburn P.
    Diagn Microbiol Infect Dis; 1993 Aug 07; 17(4):265-70. PubMed ID: 8112040
    [Abstract] [Full Text] [Related]

  • 19. Antimicrobial properties of erythromycin and colistin impregnated bone cement. An in vitro analysis.
    Ruzaimi MY, Shahril Y, Masbah O, Salasawati H.
    Med J Malaysia; 2006 Feb 07; 61 Suppl A():21-6. PubMed ID: 17042224
    [Abstract] [Full Text] [Related]

  • 20. Lysostaphin-coated catheters eradicate Staphylococccus aureus challenge and block surface colonization.
    Shah A, Mond J, Walsh S.
    Antimicrob Agents Chemother; 2004 Jul 07; 48(7):2704-7. PubMed ID: 15215130
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.